Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome.

van der Vuurst de Vries RM, Mescheriakova JY, Wong YYM, Runia TF, Jafari N, Samijn JP, de Beukelaar JWK, Wokke BHA, Siepman TAM, Hintzen RQ.

JAMA Neurol. 2018 Nov 1;75(11):1392-1398. doi: 10.1001/jamaneurol.2018.2160.

2.

Smoking at time of CIS increases the risk of clinically definite multiple sclerosis.

van der Vuurst de Vries RM, Mescheriakova JY, Runia TF, Siepman TAM, Wokke BHA, Samijn JPA, Hintzen RQ.

J Neurol. 2018 May;265(5):1010-1015. doi: 10.1007/s00415-018-8780-4. Epub 2018 Feb 20.

3.

Decreased cerebral perfusion in Duchenne muscular dystrophy patients.

Doorenweerd N, Dumas EM, Ghariq E, Schmid S, Straathof CS, Roest AA, Wokke BH, van Zwet EW, Webb AG, Hendriksen JG, van Buchem MA, Verschuuren JJ, Asllani I, Niks EH, van Osch MJ, Kan HE.

Neuromuscul Disord. 2017 Jan;27(1):29-37. doi: 10.1016/j.nmd.2016.10.005. Epub 2016 Oct 17.

PMID:
27927595
4.

T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patients.

Wokke BH, Van Den Bergen JC, Hooijmans MT, Verschuuren JJ, Niks EH, Kan HE.

Muscle Nerve. 2016 Jan;53(1):38-43. doi: 10.1002/mus.24679. Epub 2015 Nov 26.

PMID:
25847364
5.

Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severity.

van den Bergen JC, Wokke BH, Hulsker MA, Verschuuren JJ, Aartsma-Rus AM.

Neuromuscul Disord. 2015 Mar;25(3):231-7. doi: 10.1016/j.nmd.2015.01.002. Epub 2015 Jan 14.

PMID:
25633150
6.

Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophy.

Wokke BH, Hooijmans MT, van den Bergen JC, Webb AG, Verschuuren JJ, Kan HE.

NMR Biomed. 2014 Nov;27(11):1371-7. doi: 10.1002/nbm.3199. Epub 2014 Sep 6.

PMID:
25196814
7.

Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.

Doorenweerd N, Straathof CS, Dumas EM, Spitali P, Ginjaar IB, Wokke BH, Schrans DG, van den Bergen JC, van Zwet EW, Webb A, van Buchem MA, Verschuuren JJ, Hendriksen JG, Niks EH, Kan HE.

Ann Neurol. 2014 Sep;76(3):403-11. doi: 10.1002/ana.24222. Epub 2014 Jul 24.

PMID:
25043804
8.

Temporalis muscle hypertrophy and reduced skull eccentricity in Duchenne muscular dystrophy.

Straathof CS, Doorenweerd N, Wokke BH, Dumas EM, van den Bergen JC, van Buchem MA, Hendriksen JG, Verschuuren JJ, Kan HE.

J Child Neurol. 2014 Oct;29(10):1344-8. doi: 10.1177/0883073813518106. Epub 2014 Mar 19.

PMID:
24646504
9.

Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy.

Wokke BH, van den Bergen JC, Versluis MJ, Niks EH, Milles J, Webb AG, van Zwet EW, Aartsma-Rus A, Verschuuren JJ, Kan HE.

Neuromuscul Disord. 2014 May;24(5):409-16. doi: 10.1016/j.nmd.2014.01.015. Epub 2014 Feb 8.

PMID:
24613733
10.

Forty-Five Years of Duchenne Muscular Dystrophy in The Netherlands.

van den Bergen JC, Ginjaar HB, van Essen AJ, Pangalila R, de Groot IJ, Wijkstra PJ, Zijnen MP, Cobben NA, Kampelmacher MJ, Wokke BH, de Coo IF, Fock JM, Horemans AM, van Tol M, Vroom E, Rijlaarsdam ME, Straathof CS, Niks EH, Verschuuren JJ.

J Neuromuscul Dis. 2014;1(1):99-109.

PMID:
27858664
11.

Dystrophin levels and clinical severity in Becker muscular dystrophy patients.

van den Bergen JC, Wokke BH, Janson AA, van Duinen SG, Hulsker MA, Ginjaar HB, van Deutekom JC, Aartsma-Rus A, Kan HE, Verschuuren JJ.

J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):747-53. doi: 10.1136/jnnp-2013-306350. Epub 2013 Nov 29.

PMID:
24292997
12.

Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy.

van den Bergen JC, Schade van Westrum SM, Dekker L, van der Kooi AJ, de Visser M, Wokke BH, Straathof CS, Hulsker MA, Aartsma-Rus A, Verschuuren JJ, Ginjaar HB.

J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):92-8. doi: 10.1136/jnnp-2012-304729. Epub 2013 May 10.

PMID:
23667215
13.

Comparison of dixon and T1-weighted MR methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients.

Wokke BH, Bos C, Reijnierse M, van Rijswijk CS, Eggers H, Webb A, Verschuuren JJ, Kan HE.

J Magn Reson Imaging. 2013 Sep;38(3):619-24. doi: 10.1002/jmri.23998. Epub 2013 Jan 4.

PMID:
23292884

Supplemental Content

Loading ...
Support Center